Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients
- 1 July 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 33 (7) , 811-819
- https://doi.org/10.1001/archpsyc.1976.01770070041003
Abstract
• Hospitalized bipolar and unipolar endogenously depressed patients who showed an antidepressant response to the monoamine oxidase (MAO) inhibitor, tranylcypromine sulfate, relapsed (ie, depression returned) when relatively small doses of parachlorophenylalanine (PCPA) were added for brief periods. Considered together with our findings that PCPA similarly reversed the antidepressant effects of the tricyclic drug, imipramine hydrochloride, implications are (1) serotonergic mechanisms are likely involved in the antidepressant effects of both the tricyclic drugs and MAO inhibitors in man and (2) this indolamine may also play a role in the endogenous clinical state of depression.Keywords
This publication has 9 references indexed in Scilit:
- Serotonin: RadioimmunoassayScience, 1973
- EFFECT OF PHYSICAL ACTIVITY ON URINARY M.H.P.G. EXCRETION IN DEPRESSED PATIENTSThe Lancet, 1972
- Depression spectrum disease: Description and family studyComprehensive Psychiatry, 1972
- Lithium in maniaClinical Pharmacology & Therapeutics, 1970
- Toward a Biology of Depression: Some Suggestions from NeurophysiologyAmerican Journal of Psychiatry, 1969
- The Pharmacology of para-Chlorophenylalanine, a Selective Depletor of Serotonin StoresPublished by Elsevier ,1968
- Inhibition of Serotonin Synthesis by Para-Chlorophenylalanine in Patients with the Carcinoid SyndromeNew England Journal of Medicine, 1967
- The Biochemistry of Affective DisordersThe British Journal of Psychiatry, 1967
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960